The legal cannabis industry in the United States has grown into a multi-billion dollar market, yet access to traditional banking and lending services remains one of the most significant obstacles facing cannabis operators. For private lenders willing to navigate the complex regulatory framework, cannabis-related real estate and business lending represents a high-yield opportunity with substantial demand.
The Banking Gap in Cannabis Finance
Despite cannabis being legal for medical or adult recreational use in the majority of U.S. states, federal classification of marijuana as a Schedule I controlled substance under the Controlled Substances Act continues to create a fundamental conflict for financial institutions. Banks and credit unions operating under federal charters and FDIC insurance face regulatory risk when serving cannabis businesses, even those operating in full compliance with state law.
This federal-state disconnect has produced a financing vacuum. Cannabis businesses that generate hundreds of millions in annual revenue often cannot access basic checking accounts, let alone commercial loans or lines of credit. The result is an industry that remains heavily cash-dependent and chronically underbanked.
For private lenders, this gap represents a significant market opportunity. Cannabis operators need capital for facility buildouts, equipment purchases, real estate acquisitions, and working capital. Without access to conventional bank financing, these businesses are willing to accept lending terms that reflect the additional regulatory risk, including interest rate premiums and enhanced collateral requirements.
Federal Legislative Developments Shaping the Market
Several pieces of federal legislation have moved through Congress in recent years seeking to address the banking challenges facing the cannabis industry.
The SAFE Banking Act
The Secure and Fair Enforcement Banking Act (SAFE Banking Act) has been one of the most closely watched pieces of cannabis-related legislation. The Act would prohibit federal banking regulators from penalizing financial institutions solely for providing services to state-legal cannabis businesses. It would also protect lenders and landlords serving the cannabis industry from federal prosecution related to marijuana’s Schedule I status.
The SAFE Banking Act has passed the U.S. House of Representatives multiple times and has continued to gain bipartisan support. While Senate passage has proven more challenging, the legislative trajectory suggests that some form of cannabis banking protection is increasingly likely in the near term.
Rescheduling and the DEA Review
Beyond legislative action, the federal government has also initiated administrative review of marijuana’s scheduling classification. The Department of Health and Human Services recommended rescheduling marijuana from Schedule I to Schedule III, and the DEA has undertaken its own rulemaking process to evaluate this change. Reclassification to Schedule III would not fully legalize marijuana at the federal level, but it would remove some of the most significant barriers to financial services access and would eliminate the punitive tax treatment cannabis businesses face under Internal Revenue Code Section 280E.
How Private Lenders Structure Cannabis-Related Loans
Private lenders who choose to participate in cannabis-related lending have developed several structural approaches to manage the unique risks involved.
Real Estate-Secured Lending
The most common approach for private lenders entering the cannabis space is to focus on the real estate component rather than the cannabis operations themselves. This typically involves lending to property owners who lease space to cannabis cultivators, processors, or dispensaries. By securing the loan against the real property rather than the cannabis business or its inventory, lenders maintain a more conventional collateral position.
This structure offers several advantages. The property itself retains value independent of the cannabis tenant, providing a fallback if the tenant defaults or if regulatory changes force business closure. Lenders can evaluate the property using traditional appraisal methods and underwriting criteria while adding a risk premium to the interest rate to account for the cannabis use.
Interest Rate Premiums
Cannabis-related loans typically carry interest rates 100 to 300 basis points above comparable non-cannabis commercial real estate loans. This premium compensates lenders for the additional regulatory uncertainty, the more limited pool of replacement tenants if the cannabis operator vacates, and the enhanced compliance and monitoring requirements associated with these transactions.
Enhanced Due Diligence Requirements
Lenders making cannabis-related loans must conduct thorough due diligence beyond standard underwriting:
- State licensing verification confirms the cannabis tenant holds all required state and local licenses and is operating in compliance with applicable regulations.
- Local zoning and land use review ensures the property is properly zoned for cannabis operations and that the municipality has not imposed moratoriums or restrictive ordinances that could jeopardize the tenant’s ability to operate.
- Anti-money laundering (AML) compliance is essential. Lenders must implement robust AML procedures, including enhanced Know Your Customer (KYC) protocols, suspicious activity monitoring, and detailed transaction documentation. FinCEN guidance requires financial institutions serving cannabis businesses to file specific suspicious activity reports (SARs) and maintain heightened monitoring.
- Title insurance considerations can present challenges, as some title insurance companies remain reluctant to issue policies on properties actively used for cannabis operations. Lenders should identify title companies willing to insure these transactions early in the process.
State-Level Regulatory Variation Creates Complexity
One of the greatest challenges in cannabis lending is the patchwork of state regulations governing the industry. Each state that has legalized cannabis has implemented its own licensing framework, operational requirements, and compliance standards. What is permissible in California may be prohibited in a neighboring state, and local municipalities within a single state may adopt vastly different approaches to cannabis zoning and permitting.
Private lenders operating across multiple states must develop jurisdiction-specific underwriting criteria and maintain current knowledge of regulatory changes in each market where they deploy capital. Working with legal counsel experienced in both cannabis regulation and private lending law is essential to navigating this complexity.
The Investment Thesis for Cannabis Real Estate
Beyond the lending premium, the underlying real estate fundamentals in cannabis markets offer additional support for lender confidence.
Cannabis cultivation and processing facilities require substantial tenant improvements, including specialized HVAC systems, lighting, security infrastructure, and environmental controls. These improvements represent significant capital investment by tenants, creating strong economic incentive to maintain lease obligations. Tenant retention rates for cannabis facilities tend to run higher than conventional commercial properties as a result.
Additionally, zoning restrictions in many jurisdictions limit the number of properties suitable for cannabis operations. This supply constraint supports property values and provides lenders with stronger collateral positions than might be expected given the regulatory uncertainty.
Risk Factors Lenders Must Consider
Despite the attractive yield and growing market acceptance, cannabis lending carries meaningful risks that require careful management:
Regulatory reversal at the state or local level could force tenant closures and leave properties without income. While wholesale reversal of legalization is considered unlikely, local moratoriums and restrictive ordinance changes remain possible.
Federal enforcement actions, though currently restrained by congressional spending riders and DOJ policy, remain a theoretical risk as long as marijuana retains its Schedule I classification.
Market saturation in certain states has driven cannabis product prices down significantly, squeezing operator margins and increasing the risk of tenant default. States that have issued large numbers of cultivation and retail licenses have experienced the most pronounced price compression.
Insurance limitations persist for cannabis properties. Some property and casualty insurers exclude cannabis-related claims, and lenders must verify that adequate insurance coverage is in place before closing.
Building a Cannabis Lending Strategy with Legal Guidance
For private lenders evaluating cannabis-related lending opportunities, the combination of premium yields, strong real estate fundamentals, and a regulatory trajectory favoring greater federal acceptance creates a compelling market segment. However, the legal and compliance complexities demand specialized expertise.
The attorneys at Geraci LLP advise private lenders on structuring cannabis-related loans, navigating multi-state regulatory requirements, ensuring AML and licensing compliance, and protecting lender interests through appropriate documentation and collateral structures. With deep experience in private lending law and real estate finance, Geraci LLP helps lenders capitalize on emerging opportunities while managing the unique risks of this rapidly evolving market.
For questions about cannabis business lending, private lending compliance, or real estate finance, contact Geraci LLP at (949) 403-3488 or visit our offices at 90 Discovery, Irvine, CA 92618.
